S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
NASDAQ:VERO

Venus Concept (VERO) Stock Price, News & Analysis

$0.69
-0.03 (-4.16%)
(As of 03/28/2024 ET)
Today's Range
$0.68
$0.76
50-Day Range
$0.64
$1.86
52-Week Range
$0.60
$4.70
Volume
36,671 shs
Average Volume
33,964 shs
Market Capitalization
$3.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Venus Concept MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.68mentions of Venus Concept in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($5.72) to ($2.19) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.48 out of 5 stars

VERO stock logo

About Venus Concept Stock (NASDAQ:VERO)

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

VERO Stock Price History

VERO Stock News Headlines

This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Venus Concept (VERO) to Release Earnings on Monday
Venus Concept Launches "NEXThetics" Program
Venus Concept Launches “NEXThetics” Program
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Venus Concept Inc VERO
Venus Concept Launches Venus Prime
BTIG Keeps Their Hold Rating on Venus Concept (VERO)
See More Headlines
Receive VERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2023
Today
3/29/2024
Next Earnings (Confirmed)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:VERO
Fax
N/A
Employees
384
Year Founded
N/A

Profitability

Net Income
$-43,700,000.00
Pretax Margin
-44.30%

Debt

Sales & Book Value

Annual Sales
$99.50 million
Book Value
$1.77 per share

Miscellaneous

Free Float
2,688,000
Market Cap
$3.82 million
Optionable
Not Optionable
Beta
0.66
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives


VERO Stock Analysis - Frequently Asked Questions

Should I buy or sell Venus Concept stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" VERO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VERO, but not buy additional shares or sell existing shares.
View VERO analyst ratings
or view top-rated stocks.

How have VERO shares performed in 2024?

Venus Concept's stock was trading at $1.18 at the start of the year. Since then, VERO shares have decreased by 41.4% and is now trading at $0.6910.
View the best growth stocks for 2024 here
.

Are investors shorting Venus Concept?

Venus Concept saw a decline in short interest in March. As of March 15th, there was short interest totaling 12,900 shares, a decline of 72.1% from the February 29th total of 46,300 shares. Based on an average trading volume of 536,300 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.3% of the company's shares are short sold.
View Venus Concept's Short Interest
.

When is Venus Concept's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our VERO earnings forecast
.

How can I listen to Venus Concept's earnings call?

Venus Concept will be holding an earnings conference call on Monday, April 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13744647".

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) posted its quarterly earnings results on Monday, March, 27th. The company reported ($2.10) earnings per share for the quarter, meeting the consensus estimate of ($2.10). The company earned $24.29 million during the quarter. Venus Concept had a negative trailing twelve-month return on equity of 1,279.43% and a negative net margin of 43.69%. During the same period in the prior year, the firm earned ($1.20) EPS.

When did Venus Concept's stock split?

Venus Concept shares reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD).

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VERO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners